Hepatitis C Virus Therapy
Researchers from Autonomous University detail new studies and findings in the area of hepatitis C virus therapy
Published in Hepatitis Weekly, October 1st, 2007
New research, "Clinical and pathological characteristics and response to combination therapy of genotype 4 chronic hepatitis C patients: experience from a spanish center," is the subject of a report. "This observational study evaluated the characteristics of genotype 4 chronic hepatitis C (CHC) patients and their response to combination therapy in Spain. 383 patients with CHC, 44 with genotype 4-HCV infection, were investigated. Nineteen genotype 4-HCV infected patients received IFNalpha-2b (3 MU three times weekly) plus ribavirin (1-1.2 g/day) and ten received Peg-IFNalpha-2b (1.5 microg/kg/week) plus ribavirin (1-1.2 g/day) for 12 months," scientists in Spain report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-10-01)
More Articles from Hepatitis Weekly
- Hepatitis A Virus
Dutton Associates Announces Investment Opinion: Sinovac Biotech Strong Speculative Buy Rating In Initiating Coverage By Dutton Associates - Hepatitis B Virus
CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein - Hepatitis B Virus
Dynavax's HEPLISAV Hepatitis B Vaccine Maintains Full Immunogenicity at 50 Weeks in Phase 3 Trial - Hepatitis C Virus
Idera Pharmaceuticals Initiates Phase 1 Trial of IMO-2125 in Hepatitis C - Hepatitis C Virus
The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine - HIV/AIDS
Roche Real-Time HIV Test is Faster and Less Labor-Intensive Than Competitor's - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
